Date
01 September 2020
Transparency is essential to access to medicines
In this viewpoint for Medicines Patent Pool's '10 Years of MPP' campaign, Executive Director, Jayasree K. Iyer, discusses the need for transparency from pharmaceutical companies in order to improve access to medicine.
Direct links
Whether medicines, vaccines and other products reach the people who need them, especially those in low- and middle-income countries, depends on the strategic choices companies make to support affordable access. This viewpoint stresses the need for pharma companies to be transparent about their activities in order to make their medicines more accessible and affordable.
Read the article on the Medicines Patent Pool website.